Aa. Safa et al., UNDETECTABLE SERUM PROSTATE-SPECIFIC ANTIGEN ASSOCIATED WITH METASTATIC PROSTATE-CANCER - A CASE-REPORT AND REVIEW OF THE LITERATURE, American journal of clinical oncology, 21(4), 1998, pp. 323-326
A 63-year-old man, who had undergone prostatectomy for prostate cancer
that was positive for prostate-specific antigen (PSA) was examined an
d found to have metastatic disease, proven radiologically and patholog
ically, but with an undetectable PSA and highly elevated prostatic aci
d phosphatase (PAP). Prostatic acid phosphatase levels fell in respons
e to chemotherapy but his clinical status continued to deteriorate. A
review of the literature is presented and several possible explanation
s for PSA remaining undetectable in these situations are discussed. Th
e authors conclude that although PSA can be used to monitor the majori
ty of patients postprostatectomy, physicians may still need to rely on
clinical suspicion, serum PAP, and bone scan for the detection of rec
urrent disease.